LumiraDx: Q1 Earnings Insights

LumiraDx (NASDAQ:LMDX) reported its Q1 earnings results on Tuesday, May 16, 2023 at 07:45 AM. Here’s what investors…

LumiraDx (NASDAQ:LMDX) reported its Q1 earnings results on Tuesday, May 16, 2023 at 07:45 AM.

Here’s what investors need to know about the announcement.

Earnings

LumiraDx beat estimated earnings by 7.14%, reporting an EPS of $-0.13 versus an estimate of $-0.14.

Revenue was down $104.24 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 10.47% drop in the share price the next day.

Here’s a look at LumiraDx’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.20 -0.26 -0.26 -0.06
EPS Actual -0.12 -0.21 -0.31 -0.13
Revenue Estimate 41.75M 37.39M 53.09M 113.13M
Revenue Actual 41.12M 42.22M 44.73M 126.41M

To track all earnings releases for LumiraDx visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Delta 9 Cannabis’ Q1 Revenue Drops Slightly YoY, Gross Profit Grows 10%

Delta 9 Cannabis Inc. announced on Wednesday financial and operating results for the three months ending March 31, 2024."During the first quarter, we continued to focus on sustaining revenues across our core business units while optimizing our margins," John Arbuthnot, CEO of Delta 9, said. "We will continue our relentless focus on cost and operational efficiencies and strengthening our balance sheet to deliver sustained, profitable growth for our shareholders

DLTNF